ADC Therapeutics (ADCT) EBT (2020 - 2026)
ADC Therapeutics (ADCT) posted quarterly EBT of -$33.0 million for Q1 2026, up 14.23% year-on-year from -$28.9 million in Q1 2025, and up 19.52% on a QoQ basis from -$41.0 million in Q3 2025.
ADC Therapeutics (ADCT) EBT (2020 - 2026) Analysis & Trends
ADC Therapeutics (ADCT) has reported EBT for 7 consecutive years, with -$33.0 million the latest figure, recorded in Q1 2026.
- Quarterly EBT rose 14.23% year-over-year to -$33.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$167.8 million (down 2.56% YoY) and the FY2022 annual result came in at -$152.6 million, up 33.84% from the prior year.
- EBT grew to -$33.0 million in Q1 2026 per ADCT's latest filing, from -$41.0 million in the prior quarter.
- Over the last five years, EBT for ADCT reached as high as -$17.8 million in Q1 2022 and fell as low as -$65.3 million in Q2 2022.
- A 5-year average of -$43.1 million and a median of -$44.5 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT surged 65.32% — and 2023, when it sank 234.74%.
- Year by year, EBT stood at -$18.2 million in 2022, then tumbled by 150.11% to -$45.4 million in 2023, then grew by 3.93% to -$43.6 million in 2024, then advanced by 6.08% to -$41.0 million in 2025, then climbed by 19.52% to -$33.0 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$33.0 million, -$41.0 million, and -$55.4 million for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | ADC Therapeutics | 189.60 Mn | -41.41 Mn | 17.38 Mn | -32.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.97 Mn |
| Sep 30, 2025 | -40.97 Mn |
| Jun 30, 2025 | -55.39 Mn |
| Mar 31, 2025 | -38.44 Mn |
| Sep 30, 2024 | -43.62 Mn |
| Jun 30, 2024 | -35.71 Mn |
| Mar 31, 2024 | -45.80 Mn |
| Sep 30, 2023 | -45.40 Mn |
| Jun 30, 2023 | -52.70 Mn |
| Mar 31, 2023 | -59.69 Mn |
| Dec 31, 2022 | -18.15 Mn |
| Sep 30, 2022 | -51.32 Mn |
| Jun 30, 2022 | -65.32 Mn |
| Mar 31, 2022 | -17.83 Mn |
| Dec 31, 2021 | -35.52 Mn |
| Sep 30, 2021 | -71.40 Mn |
| Jun 30, 2021 | -72.33 Mn |
| Mar 31, 2021 | -51.42 Mn |
| Dec 31, 2020 | -56.26 Mn |
| Sep 30, 2020 | -20.33 Mn |